Fact CheckerSign in

NCT06443268Recruiting

Cerebrovascular Disease: Quality of Life (CODE: QoL)

Source: ClinicalTrials.gov · Last updated 5 Jun 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this observational study is to learn about quality of life, stress and caregiver burden in patients with stroke and their caregivers. The main question is: • to discover the factors associated with quality of life and stress in patient-caregiver dyads. Participants will be asked to fill out questionnaires and agree to provide a hair sample (in order to measure stress hormones in hair) and consent to use of their routine clinical and laboratory data. Researchers will compare a group of participants without stroke to establish a comparable baseline.

Status (registry)
Recruiting
Study type
Observational
Enrollment
680 (estimated)
First submitted
4 May 2024
Start date
27 May 2023
Primary completion date
30 Apr 2028
Lead sponsor
University of Zurich
Diseases
Stroke
NCT number
NCT06443268

What you commit to

  • Study type: Observational
  • Planned participants: 680
  • From 27 May 2023 to the primary completion date, 30 Apr 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Medication with steroid hormones (prednisone, prednisolone, dexamethasone, methylprednisolone, hydrocortisone etc.) within last 3 months
    • Main Group:
  • Medication with steroid hormones (prednisone, prednisolone, dexamethasone, methylprednisolone, hydrocortisone etc.) within last 3 months

Who the study is looking for

  • over 18 years old
  • No previous stroke OR previous stroke \>3 years ago
  • No significant disability (maximum mRS 1)
  • ambulatory patients at the University Hospital of Zurich (USZ), Dept. of Neurology
  • Patients' AND caregiver's ability to give informed consent
  • Patients' AND close relative's / caregiver's willingness to participate
  • over 18 years old
  • Patients diagnosed with either transient ischemic attack, ischemic stroke or intracerebral hemorrhage and their caregivers
  • Caregiver of a patient as described above, age over 18 years
  • Hospitalized or ambulatory patients at the University Hospital of Zurich (USZ) included within 28 days from event.
  • Patients' AND caregiver's ability to give informed consent
  • Patients' AND caregiver's willingness to participate

Criteria the registry did not label

  • Control group:

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Neurology, University Hospital Zurich
Coordinator of this site? Confirm its status
ZurichSwitzerlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.